Semaglutide was linked to greater weight loss and a 15% lower fracture risk in people with type 2 diabetes, raising the possibility of an unexpected bone health benefit. People with type 2 diabetes who took semaglutide experienced greater weight loss and a lower risk of bone fractures than those using several other weight-loss medications, according [...]
Semaglutide delivered dramatic weight loss and health benefits in adults over 65, offering new hope for healthier aging. A new analysis of data from the STEP clinical trial program suggests that semaglutide remains both effective and generally safe for older adults living with obesity. The research, conducted by Prof. Luca Busetto of the University of [...]
After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.
Jesse Gabriel "has passed more food policy in three years than most legislators enact in their entire careers," says one supporter.
A large international study found that an experimental oral diabetes medication produced significant improvements in both glucose control and weight loss. For millions of people with type 2 diabetes, GLP-1 drugs have transformed treatment by helping lower blood sugar while also promoting weight loss. But many of the most effective options still require injections, creating [...]
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.
An endocrinologist’s new weight-care system halted population-level weight gain and could reshape obesity treatment across America. For years, endocrinologist Leigh Perreault, MD, believed there had to be a more effective way to help people manage their weight than simply advising them to eat healthier and exercise more. “There was a moment I put my face [...]
According to the NHS, one in three of us will experience sleep issues at least once in our lives
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference.
Boehringer Ingelheim’s obesity drug showed promise in cutting liver fat, but it was less impressive at overall weight loss, new data shows.
Scientists found that a tomato-soy juice rich in plant-derived compounds altered inflammation-related signals in healthy adults with obesity. A new study found that drinking tomato-soy juice rich in health-promoting plant compounds reduced levels of inflammatory proteins in healthy adults with obesity after four weeks. The results suggest the beverage could serve as a functional food [...]
A new study suggests that lingering rheumatoid arthritis symptoms are not always caused by ongoing inflammation. For people with rheumatoid arthritis, lingering pain and fatigue are often assumed to be signs that inflammation remains active. But new research suggests the real culprit may sometimes lie elsewhere. Researchers at Semmelweis University report that sleep disorders, depression, [...]
Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.
Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.
A widely prescribed class of weight-loss and diabetes medications may be doing more than improving metabolic health. Drugs such as Ozempic and Wegovy have transformed the treatment of obesity and type 2 diabetes, helping millions lose weight and improve metabolic health. But scientists are increasingly uncovering effects that extend far beyond the scale. Research has [...]
A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.
A new AI framework called MouseMapper allows scientists to examine disease-related changes across the entire body at cellular resolution. Obesity does much more than affect metabolism and fat storage. It also changes immune activity, nerve structure, and tissue organization throughout the body, raising the risk of conditions such as type 2 diabetes, cardiovascular disease, stroke, [...]
For years, medicine has tried to eliminate stigma. Now, Robert F. Kennedy Jr. is bringing back the language of personal responsibility.
Stopping Ozempic doesn’t always lead to major weight regain, according to a large new study. As injectable GLP-1 medications become increasingly popular, one question continues to come up: What happens when people stop taking them? A new Cleveland Clinic study involving nearly 8,000 patients suggests that, in everyday clinical practice, stopping semaglutide or tirzepatide does [...]
With a endoscopic sleeve gastroplasty, the stomach is stitched smaller from the inside and instead of doctors making abdominal incisions, the tools go down the patient's throat.
Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users push past plateaus that not even this "wonder drug" can circumvent.
Continue Reading
Category: Obesity, Illnesses and conditions, Body and Mind
Tags: National Institutes of Health (NIH), U.S. National…
Once-weekly interval walking may be as effective as exercising three times weekly for reducing body fat and improving fitness in adults with central obesity. A new study suggests that getting fit may not require squeezing in workouts several times a week after all. Researchers at the School of Public Health at the LKS Faculty of [...]
A new “Trojan horse” weight-loss drug sneaks extra metabolic power into cells and delivers striking results in mice. Researchers at Helmholtz Munich have developed a new drug strategy that could improve treatment for obesity and type 2 diabetes. Led by metabolism scientist Prof Timo D. Müller, the team created a hybrid molecule that uses the [...]
"Weight loss injections have become a global sensation - but if not used properly can strip you of muscle and bone mass"
Pamela Phillips, 42, explained why weight loss injections were not a long term solution for her - before losing the weight another, more traditional way
World leading experts on obesity tell the Mirror why diets almost always fail eventually and why appetite-suppressing drugs offer hope - but come with big risks
Body weight may play a larger role in brain aging than previously understood. A number on the scale may say more about future brain health than previously recognized. New research from the University of Georgia suggests that higher body mass index, or BMI, may be linked to faster cognitive decline in older adults. The finding [...]
An illustration of a person standing on a scale
Intake of too little dietary fiber and too much added sugar is a major contributor to obesity, type 2 diabetes, and heart disease. One major source of added sugar is traditional soda, which has long been linked to obesity, cardiovascular disease, kidney problems, fatty liver disease, tooth decay, and other health complications.
Continue Reading
Category: Diet & Nutrition, Wellness and…